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Background and Purpose. Paroxysmal Atrial ﬁbrillation/Flutter (PAF) detection rates in cryptogenic strokes have been variable.
We sought to determine the percentage of patients with cryptogenic stroke who had PAF on prolonged non-invasive cardiac
monitoring. Methods and Results. Sixty-two consecutive patients with stroke and TIA in a single center with a mean age of 61
(+/− 14) years were analyzed. PAF was detected in 15 (24%) patients. Only one patient reported symptoms of shortness of breath
during the episode of PAF while on monitoring, and 71 (97%) of these 73 episodes were asymptomatic. A regression analysis
revealed that the presence of PVCs (ventricular premature beats) lasting more than 2 minutes (OR 6.3, 95% CI, 1.11–18.92;
P = .042) and strokes (high signal on Diﬀusion Weighted Imaging) (OR 4.3, 95% CI, 5–36.3; P = .041) predicted PAF. Patients
with multiple DWI signals were more likely than solitary signals to have PAF (OR 11.1, 95% CI, 2.5–48.5, P<. 01). Conclusion.
Occult PAF is common in cryptogenic strokes, and is often asymptomatic. Our data suggests that up to one in ﬁve patients with
suspected cryptogenic strokes and TIAs have PAF, especially if they have PVCs and multiple high DWI signals on MRI.
1.Introduction
Atrial ﬁbrillation/ﬂutter both persistent and paroxysmal are
signiﬁcant risk factors for cardioembolic ischemic stroke
and is often asymptomatic [1, 2]. Atrial Fibrillation (both
persistent and paroxysmal) are signiﬁcant predictors of ﬁrst
and recurrent cerebrovascular and cardiac events, with more
than 75 000 cases of stroke per year ascribed to AF (atrial
Fibrillation) in the United States [3]. Oral anticoagulant
therapy is the keystone of management of such patients,
whichreducesrecurrencesofstrokeandstrokeseverity[4,5].
A baseline electrocardiogram and routine Holter monitoring
detects AF in up to 5–7 percent of patients with ischemic
strokes within the ﬁrst 72 hours [6, 7]. A large proportion
of strokes, up to 40% in some reports, has no apparent
etiology on routine diagnostic testing and is often classiﬁed
as cryptogenic strokes [8]. The etiology of some of these
strokes, however, may be cardioembolic even though the
initial diagnostic evaluation may be negative.
Cardiac monitors have improved our capabilities to
investigate the presence of paroxysmal atrial ﬁbrillation or
ﬂutter (PAF) in patients with stroke for longer time periods.
H i g h e rd e t e c t i o nr a t e so fP A Fh a v eb e e nr e p o r t e dw i t h
prolonged cardiac monitoring in patients with cryptogenic
cerebrovascular events [9]. We investigated our cohort of
cryptogenic stroke patients and sought to determine the
percentage of patients who presented to our institution with
cryptogenic strokes who have PAF on long-term monitoring.
We also sought predictors of PAF in patients with crypto-
genic strokes.
2. Methods
Between July 2007 to March 2010, we studied and retro-
spectively analyzed 62 consecutive patients with cryptogenic
stroke (n = 50) or TIA (n = 12) who underwent
prolonged non-invasive cardiac monitoring up to 28 days2 Stroke Research and Treatment
Table 1: Patient characteristics.
Characteristics Total Aﬁb No-Aﬁb
N = 62 N = 15 N = 47
Mean age 61 years 64 59
Female (n = 30) 48% 52% 48%
HTN (n = 16) 26% 27% 23%
CAD (n = 8) 13% 20% 11%
DM (n = 3) 5% 6% 4%
Dyslipidemia (n = 26) 42% 45% 41%
Mean EF (ejection fraction) 58% 56% 59%
Percentage getting TEE (n = 59) (transesophageal echocardiogram) 95% 93% 96%
Percentage getting CTA (CTAngiogram) 100% 100% 100%
after discharge. These represented 10 percent of the total
ischemic stroke and TIA population (n = 629). We sought
to determine the percentage of patients with cryptogenic
stroke (high signal on DWI) or TIA (symptoms lasting
<24 hours and DWI imaging negative) who had PAF on
prolonged outpatient non-invasive cardiac monitoring. This
r e t r o s p e c t i v es t u d yw a sa p p r o v e db yI R B .
2.1. Non-Invasive Cardiac Monitoring. CardioNet MCOT
(Conshohocken, PA), is a pocket-sized device worn by
patients for up to 28 days for cardiac rhythm monitoring.
Patients wear three chest leads attached to a small sensor that
detects heartbeats and wirelessly transmits this information
to the monitor. The monitor analyzes each heartbeat, detects
arrhythmias, and transmits each event to the CardioNet
monitoring center via a built-in cellular modem. Patients
keep a log of their symptoms. Episodes of PAF were deﬁned
by duration of more than or 30 seconds [2]. The duration
andfrequencyofPAFepisodes wererecorded.Manualreview
was done by 2 physicians to conﬁrm the presence or absence
of PAF episodes was recorded. The cardiologist report which
was considered gold standard.
2.2. Statistical Analysis. Data was analyzed retrospectively.
We performed logistic regression analysis (P<. 05 with 95%
CI) to determine factors predicting presence or absence of
PAF. All analyses were done using (SPSSinc, IBM).
3. Results
Sixty-two consecutive patients (Table 1)wi t hs tr o k e( n = 50)
and TIA (n = 12), with mean age of 61 (± 14) years,
were analyzed. All patients underwent an MRI scan with
DWIimaging.Ninety-ﬁvepercentofpatientshadundergone
TEE (transesophageal echocardiogram),TTE (transthoracic
echocardiogram) with bubbles (5%), and a CT angiogram
(100%). All these tests did not reveal a cause for the stroke.
All patients had EKG on admission and at least 24 hours of
cardiac telemetry. PAF was detected in 15 (24%) patients.
The majority, 14 (93%), of the PAF was detected within the
ﬁrst 21 days (Figure 1). Median duration of non-invasive
monitoring was 21 days (range 2–28) (Figure 2), and median
day when the ﬁrst PAF episode was detected was day 7.
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Figure 1: Day PAF detected on prolonged non-invasive cardiac
monitoring.
There were 3 patients who underwent less than 7 days
of monitoring. PAF was detected early in those patients,
and monitoring was therefore terminated. A total of 73
episodes of paroxysmal PAF were detected among these
15 patients, with range (1–21) and median 5 episodes per
patient. Only one patient reported symptoms of shortness of
breath during the episode of PAF while monitoring, and 71
(97%) of these 73 episodes were apparently asymptomatic.
In patients with PAF, mean maximum heart rate was 111
and mean minimum heart rate was 74. Median start date
of non-invasive monitoring was day 29 (range 16–48) after
discharge.
A logistic regression analysis revealed that the presence
of PVCs lasting more than 2 minutes (n = 12, OR 6.32,
1.11–18.92,95%CI,P = .042)signiﬁcantlypredictedPAF.In
addition,strokes(highsignalondiﬀusionweightedimaging)
(OR 4.3, 95% CI, 5 to 36.3, P = .041) predicted PAF.
There were 50 patients with high DWI signal (strokes) and
12 patients with TIA. Multiple DWI signals were observedStroke Research and Treatment 3
Table 2: Previous studies evaluating prolonged cardiac monitoring.
Study Design Patient
selection N Device/Days Percent with PAF/Outcome
deﬁnition
Barthelemy et al, 2003 [10] Observational Ischemic
stroke or TIA 60 Cardiac monitoring
4d a y s 7.7% with PAF ≥30secs
Jabaudon et al, 2004 [11] Observational Ischemic
stroke or TIA 88 Cardiac monitoring
7d a y s 5.7% with PAF
Tayal et al, 2008 [9] Retrospective Cryptogenic
stroke or TIA 56 Cardiac monitoring
21 days 23% with any PAF
Elijovich et al, 2009 [12] Retrospective Cryptogenic
stroke or TIA 20 Cardiac monitor 30 20% with PAF ≥30secs
Zeigler et al, 2010 [13] Observational Stroke or TIA 183 Implantable deﬁb/pacer
≥21 days 29% with PAF/AT ≥5mins
Gaillard et al. 2010 [14] Observational
Cryptogenic
strokes or
TIA
98 Cardiac monitor 30 days 9.2% with PAF ≥32secs
Dion et al. 2010 [15] Observational
Cryptogenic
strokes or
TIA
24 Implantable deﬁb/pacer
≥21 days 4% with PAF ≥ 30secs
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Figure 2: Compliance in days by patients with non-invasive cardiac
monitoring.
in 20 out of 50 patients. There were 14 patients with high
DWI signal with PAF and 1 patient with TIA with PAF. Out
of the 14 patients with high DWI signals, 11 had multiple
signalsand3hadsolitarysignals.PatientswithmultipleDWI
signals were more likely than solitary signals to have PAF
(OR 11.1, 95%CI, 2.5–48.5, P< . 01). Other factors such as
age, sex, diabetes, hypertension, and heart disease were not
signiﬁcantly associated with PAF detection.
4. Discussion
Our ﬁndings indicate that around 25% of patients with
cryptogenic stroke had PAF, and most (97%) of these PAF
episodes were silent (absence of symptoms suggestive of
arrhythmia). If we used the 5-minute deﬁnition, 6 patients
(9%) had PAF. Previous studies (Table 2)r e p o r t e dP A F
detection rates ranging from 4% to 29 % on prolonged
cardiac monitoring which ranged from 4 to 30 days in
patients with strokes or TIAs. However, there was signiﬁcant
heterogeneity in the design and outcomes of those studies.
In 4 studies, [9, 12, 14, 15] which speciﬁcally studied
cryptogenic strokes, the PAF detection rate was 4–23%.
Diﬀerent types of cardiac monitors were used with variable
duration of monitoring (4–30 days). In fact, two studies
[13, 15] used implantable devices to evaluate for PAF, and
found variable results (4% to 29% detection) on longer term
monitoring (up to 1.4 years). A recent cost-eﬀective analysis
showed that non-invasive outpatient cardiac monitoring is
a cost-eﬀective option for detection of PAF in patients with
stroke [16].
The use of the term “cryptogenic” has been variable
among stroke physicians. A recent study [15]f o u n dv e r y
low incidence of PAF on long term monitoring (1/24) in
a population of cryptogenic stroke patients. However, in
that study, not all patients underwent evaluation of the
intracranial and extracranial vasculature and it is possible
that the etiology of stroke was due to atherosclerosis. In
fact, some patients only had carotid Doppler imaging. All
stroke or TIA patients in our study had a CT angiogram to
visualize the aortic arch, extracranial, and intracranial blood
vessels. In addition, 95% of patients had a TEE and 5%
had surface echo with agitated saline injection for detection
of right-to-left shunt. We believe the term “cryptogenic”
stroke should be reserved for patients who have undergone
a comprehensive cardiac and vascular work up.
The duration of monitoring may be important. In our
study, although patients were prescribed monitoring for 21–
28 days, not all patients were able to complete the full
duration of prescribed monitoring (Figure 2). Monitoring
was discontinued in three patients who underwent less than4 Stroke Research and Treatment
7 days of monitoring, as PAF was detected early. Although
previous studies have focused on monitoring for 30 days,
existing data indicate that PAF detection is possible even
beyond this time period. In a pooled estimate of stroke
patients from the Virtual International Stroke Trials Archive
data of more than 2504 patients [7],new PAFwasdetected in
6.9% patients, of which in 68% of patients, PAF was detected
after 48 hours of presentation. Another study [17] evaluating
long-term monitoring in stroke patients for more than 21
days showed that 62% of PAF cases were detected beyond the
initial 21 days of monitoring.
Previous studies used diﬀerent deﬁnitions for PAF
(Table 2). We used the ACC/AHA deﬁnition of paroxysmal
PAF [2] which is self-terminating PAF episodes lasting 30
seconds or longer. In fact, 85% of the episodes of PAF in
the study by Tayal et al. [9] did not meet the current criteria
of paroxysmal PAF. Zeigler et al. deﬁned paroxysmal PAF as
self-terminating episodes lasting 5 minutes or longer, but did
not diﬀerentiate between PAF and other atrial tachycardias.
In our study, all 15 patients satisﬁed the current ACC/AHA
deﬁnition of PAF. In addition to the 15 patients, 8 patients
hadlessthan30-secondepisodesofPAF,whichdidnotsatisfy
criteria of PAF by AHA.
Multiple high signals on DWI MRI and runs of PVCs
may help to predict PAF. In a recent study [14] using
transtelephonic evaluation, where EKGs were obtained every
day for 30 days, the detection rate was 9% (9/98). This study
also showed that positive DWI signal on MRI scan (P =
.042) and presence of >100 premature atrial contractions
(P = .007) predicted the presence of PAF. Our study,
however, showed for the ﬁrst time that presence of PVCs
for more than 2 minutes and multiple high signals on
DWI were predictive of higher detection rates of paroxysmal
PAF. A recent analysis of ARIC (atherosclerosis risk in
communities) study showed that presence of frequent PVCs
lasting more than 2 minutes were associated with increased
risk of stroke in participants free of hypertension and
diabetes [18]. In conclusion, although limited to a single
center retrospective sample, our study suggests that PAF is
common in cryptogenic stroke patients. In addition, it is
always diﬃcult to include cryptogenic TIA patients, as some
of these patients may not represent true cerebrovascular
events. However, we used traditional deﬁnition of TIA and
we acknowledge that the low number of TIA patients may
result in possibility of bias. Also, ﬁve percent (n = 3) of
patients did not have TEE in our population. They were
evaluated with TTE with bubbles (agitated saline) which
is a relatively sensitive test to detect shunt. Patients with
multiple DWI signals on MRI and PVCs lasting longer
than 2 minutes may have higher PAF prevalence rates—
this novel ﬁnding warrants further study. The majority of
the PAF episodes are asymptomatic. Whether detecting PAF
in these patients warrants change in therapy needs further
study. Further studies using larger patient population are
necessary. Sensitivity and speciﬁcity of these devices to
detect PAF needs to be evaluated in a systematic fashion.
In addition, role of implantable devices to detect PAF may
facilitate longer duration of monitoring, which needs to be
investigated.
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